LONGITUDINAL FOVEAL FLUORESCENCE LIFETIME CHARACTERISTICS IN GEOGRAPHIC ATROPHY USING FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY

Joel-Benjamin Lincke, Chantal Dysli, Damian Jaggi, Yasmin Solberg, Sebastian Wolf, Martin S Zinkernagel, Joel-Benjamin Lincke, Chantal Dysli, Damian Jaggi, Yasmin Solberg, Sebastian Wolf, Martin S Zinkernagel

Abstract

Purpose: Short foveal fluorescence lifetimes (fFLT) in geographic atrophy are typically found in eyes with foveal sparing (FS) but may also occur in eyes without FS. We investigated whether short fFLT could serve as a functional biomarker for disease progression in geographic atrophy.

Methods: Thirty three eyes were followed over the course of 4 to 6 years. Foveal sparing was assessed using fluorescence lifetime imaging ophthalmoscopy, optical coherence tomography, fundus Autofluorescence, and macular pigment optical density.

Results: Eyes with FS exhibited shorter fFLT compared with eyes without FS. Short fFLT (<600 ps) were measured in all eyes with FS and half of the eyes without FS. Eyes with FS showed a bigger increase in fFLT per year (+39/+30 ps (short spectral channel/long spectral channel) in FS versus +29/+22 ps (short spectral channel/long spectral channel) in non FS). The best-corrected distance visual acuity correlated significantly with fFLT (P = 0.018 and P = 0.005 for short spectral channel/long spectral channel). Macular pigment optical density measurements correlated significantly with fFLT but not in all spectral channels (P ranging from 0.018 to 0.077).

Conclusion: In geographic atrophy, shorter fFLT are associated with FS but they can also be observed in eyes without FS. Our longitudinal data suggest that shorter fFLT features in eyes with loss of FS represent an earlier stage of disease and may be more prone to loss of the visual acuity.

Trial registration: ClinicalTrials.gov NCT01981148.

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc.

References

    1. Schmitz-Valckenberg S. The journey of “geographic atrophy” through past, present, and future. Ophthalmologica 2017;237:11–20.
    1. Holz FG, Strauss EC, Schmitz-Valckenberg S, Campagne MvL. Geographic atrophy clinical features and potential therapeutic approaches. Ophthalmology 2014;121:1079–1091.
    1. Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis 1999;5:25.
    1. Bindewald A, Bird AC, Dandekar SS, et al. Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophth Vis Sci 2005;46:3309–3314.
    1. Holz FG, Bindewald-Wittich A, Fleckenstein M, et al. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 2007;143:463–472.
    1. Klein R, Meuer SM, Knudtson MD, Klein BEK. The epidemiology of progression of pure geographic atrophy: the beaver dam eye study. Am J Ophthalmol 2008;146:692–699.
    1. Delori FC, Dorey CK, Staurenghi G, et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophth Vis Sci 1995;36:718–729.
    1. Schmitz-Valckenberg S, Jorzik J, Unnebrink K, et al. Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration. Graefe's Archive Clin Exp Ophthalmol 2002;240:73–78.
    1. Holz FG, Bellmann C, Margaritidis M, et al. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefe's Archive Clin Exp Ophthalmol 1999;237:145–152.
    1. Sayegh RG, Sacu S, Dunavolgyi R, et al. Geographic atrophy and foveal-sparing changes related to visual acuity in patients with dry age-related macular degeneration over time. Am J Ophthalmol 2017;179:118–128.
    1. Schweitzer D, Kolb A, Hammer M, Thamm E. Basic investigations for 2-dimensional time-resolved fluorescence measurements at the fundus. Int Ophthalmol 2001;23:399–404.
    1. Schweitzer D, Hammer M, Schweitzer F, et al. In vivo measurement of time-resolved autofluorescence at the human fundus. J Biomed Opt 2004;9:1214.
    1. Schweitzer D, Schenke S, Hammer M, et al. Towards metabolic mapping of the human retina. Microsc Res Techniq 2007;70:410–419.
    1. Dysli C, Wolf S, Hatz K, Zinkernagel MS. Fluorescence lifetime imaging in stargardt disease: potential marker for disease progression. Invest Ophthalmol Vis Sci 2016;57:832–841.
    1. Sauer L, Calvo CM, Vitale AS, et al. Imaging of hydroxychloroquine toxicity with fluorescence lifetime imaging ophthalmoscopy. Ophthalmol Retina 2019;3:814–825.
    1. Solberg Y, Dysli C, Wolf S, Zinkernagel MS. Fluorescence lifetime patterns in macular telangiectasia type 2. Retina 2019;40:99–108.
    1. Sauer L, Andersen KM, Li B, et al. Fluorescence lifetime imaging ophthalmoscopy (FLIO) of macular pigment. Invest Ophth Vis Sci 2018;59:3094–3103.
    1. Sauer L, Schweitzer D, Ramm L, et al. Impact of macular pigment on fundus autofluorescence lifetimes. Invest Ophthalmol Vis Sci 2015;56:4668–4679.
    1. Dysli C, Wolf S, Zinkernagel MS. Autofluorescence lifetimes in geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 2016;57:2479–2487.
    1. Sauer L, Klemm M, Peters S, et al. Monitoring foveal sparing in geographic atrophy with fluorescence lifetime imaging ophthalmoscopy - a novel approach. Acta ophthalmologica 2018;96:257–266.
    1. Sadda SR, Guymer R, Holz FG, et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology 2018;125:537–548.
    1. Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study design and baseline patient characteristics: ETDRS report number 7. Ophthalmology 1991;98:741–756.
    1. Dennison JL, Stack J, Beatty S, Nolan JM. Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance. Exp Eye Res 2013;116:190–198.
    1. Conrady CD, Bell JP, Besch BM, et al. Correlations between macular, skin, and serum carotenoids. Invest Ophthalmol Vis Sci 2017;58:3616–3627.
    1. Akuffo KO, Nolan JM, Peto T, et al. Relationship between macular pigment and visual function in subjects with early age-related macular degeneration. Br J Ophthalmol 2017;101:190.
    1. Fleckenstein M, Adrion C, Schmitz-Valckenberg S, et al. Concordance of disease progression in bilateral geographic atrophy due to AMD. Invest Ophth Vis Sci 2010;51:637–642.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere